Professional
Added to YB: 2025-03-28
Pitch date: 2024-12-31
MCK [neutral]
McKesson Corporation
+34.5%
current return
Author Info
No bio for this author
Company Info
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$88.6B
Pitch Price
$569.90
Price Target
N/A
Dividend
0.44%
EV/EBITDA
12.75
P/E
19.21
EV/Sales
0.23
Sector
Health Care Providers and Services
Category
N/A
Conventum-Alluvium Global Fund Portfolio Holding: McKesson Corporation
MCK (reduced position): Drug distributor +15.4% on decent results, upgraded guidance. Market concerns abated. New guidance slightly above maintainable earnings view. No analysis change. Largest fund position until slight December sell-off, now 6.3% of portfolio.
Read full article (1 min)